Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dave Edwards
A Novel, Highly Potent and Selective Phosphodiesterase-9 Inhibitor for the Treatment of Sickle Cell Disease
Haematologica
Hematology
Related publications
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate
Highly Sensitive and Selective Oligonucleotide Sensor for Sickle Cell Disease Gene Using Photon Upconverting Nanoparticles
Biosensors and Bioelectronics
Electrochemistry
Nanoscience
Medicine
Biotechnology
Nanotechnology
Biophysics
Biomedical Engineering
Novel Treatment of Pulmonary Embolism in a Patient With Sickle Cell Disease
Hematology & Medical Oncology
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled Study
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
5626884 Treatment of Sickle Cell Disease
Transfusion Science
Targeting iNKT Cells for the Treatment of Sickle Cell Disease
Clinical Immunology
Allergy
Immunology
Advances in the Treatment of Sickle Cell Disease
Mayo Clinic Proceedings
Medicine
Preclinical Characterization of Anlotinib, a Highly Potent and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor
Cancer Science
Cancer Research
Medicine
Oncology
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor